UVA Health launches 2 key clinical trials to see if immunotherapy combined with FUS tumor ablation can prevent breast cancer metastasis.
Category: Oncology Innovations
These procedures offer minimally invasive options for many conditions, including early gastrointestinal cancers.
With a first-of-its-kind focused ultrasound center & trials, UVA Health is positioned to overcome immunotherapy’s cancer-metastases limitation.
Targeting fusion proteins may provide an improved therapeutic approach for leukemia patients.
A groundbreaking clinical trial at UVA Health may shift the approach to treating glioblastoma.
Todd Bauer, MD, leads a laboratory searching for what drives chemo-resistance and metastases in his pancreatic and colorectal cancer patients.
With acute myeloid leukemia classification overseen by 3 separate guidelines, Firas El Chaer, MD, is working to bring order to the chaos.
Thomas Loughran, MD, reveals the most intriguing clinical applications for his LGL and acute myeloid leukemias research.
A novel neoadjuvant approach can essentially cure a disease that often gives patients a year or less to live.
UVA Health is among the first 25 centers to bring cancer patients the MRIdian Linac, a significant advance in MR-guided radiation therapy.